Cargando…

Gastrointestinal pirfenidone adverse events in idiopathic pulmonary fibrosis depending on diet: the MADIET clinical trial

Individuals with IPF who follow a MUFA diet report a lower incidence of pirfenidone gastrointestinal adverse events than those that follow a SFA diet, which could explain the different prevalence in GI pirfenidone AEs reported by countries in IPF cohorts https://bit.ly/3LuzAUJ

Detalles Bibliográficos
Autores principales: Molina-Molina, Maria, Shull, Jessica Germaine, Vicens-Zygmunt, Vanesa, Rivera-Ortega, Pilar, Antoniou, Katerina, Bonella, Francesco, Renzoni, Elisabetta, Russell, Anne-Marie, Maher, Toby M., Vancheri, Ada, Bachs, Anna, Avilés, Victoria, Palma, Josep, Bermudo, Guadalupe, Suarez-Cuartin, Guillermo, Tebé, Cristian, Rigo-Bonnin, Raul, Montes-Worboys, Ana, Wijsenbeek, Marlies, Vancheri, Carlo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: European Respiratory Society 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10586233/
https://www.ncbi.nlm.nih.gov/pubmed/37857429
http://dx.doi.org/10.1183/13993003.00262-2023
_version_ 1785123114585161728
author Molina-Molina, Maria
Shull, Jessica Germaine
Vicens-Zygmunt, Vanesa
Rivera-Ortega, Pilar
Antoniou, Katerina
Bonella, Francesco
Renzoni, Elisabetta
Russell, Anne-Marie
Maher, Toby M.
Vancheri, Ada
Bachs, Anna
Avilés, Victoria
Palma, Josep
Bermudo, Guadalupe
Suarez-Cuartin, Guillermo
Tebé, Cristian
Rigo-Bonnin, Raul
Montes-Worboys, Ana
Wijsenbeek, Marlies
Vancheri, Carlo
author_facet Molina-Molina, Maria
Shull, Jessica Germaine
Vicens-Zygmunt, Vanesa
Rivera-Ortega, Pilar
Antoniou, Katerina
Bonella, Francesco
Renzoni, Elisabetta
Russell, Anne-Marie
Maher, Toby M.
Vancheri, Ada
Bachs, Anna
Avilés, Victoria
Palma, Josep
Bermudo, Guadalupe
Suarez-Cuartin, Guillermo
Tebé, Cristian
Rigo-Bonnin, Raul
Montes-Worboys, Ana
Wijsenbeek, Marlies
Vancheri, Carlo
author_sort Molina-Molina, Maria
collection PubMed
description Individuals with IPF who follow a MUFA diet report a lower incidence of pirfenidone gastrointestinal adverse events than those that follow a SFA diet, which could explain the different prevalence in GI pirfenidone AEs reported by countries in IPF cohorts https://bit.ly/3LuzAUJ
format Online
Article
Text
id pubmed-10586233
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher European Respiratory Society
record_format MEDLINE/PubMed
spelling pubmed-105862332023-10-20 Gastrointestinal pirfenidone adverse events in idiopathic pulmonary fibrosis depending on diet: the MADIET clinical trial Molina-Molina, Maria Shull, Jessica Germaine Vicens-Zygmunt, Vanesa Rivera-Ortega, Pilar Antoniou, Katerina Bonella, Francesco Renzoni, Elisabetta Russell, Anne-Marie Maher, Toby M. Vancheri, Ada Bachs, Anna Avilés, Victoria Palma, Josep Bermudo, Guadalupe Suarez-Cuartin, Guillermo Tebé, Cristian Rigo-Bonnin, Raul Montes-Worboys, Ana Wijsenbeek, Marlies Vancheri, Carlo Eur Respir J Research Letters Individuals with IPF who follow a MUFA diet report a lower incidence of pirfenidone gastrointestinal adverse events than those that follow a SFA diet, which could explain the different prevalence in GI pirfenidone AEs reported by countries in IPF cohorts https://bit.ly/3LuzAUJ European Respiratory Society 2023-10-19 /pmc/articles/PMC10586233/ /pubmed/37857429 http://dx.doi.org/10.1183/13993003.00262-2023 Text en Copyright ©The authors 2023. https://creativecommons.org/licenses/by-nc/4.0/This version is distributed under the terms of the Creative Commons Attribution Non-Commercial Licence 4.0. For commercial reproduction rights and permissions contact permissions@ersnet.org (mailto:permissions@ersnet.org)
spellingShingle Research Letters
Molina-Molina, Maria
Shull, Jessica Germaine
Vicens-Zygmunt, Vanesa
Rivera-Ortega, Pilar
Antoniou, Katerina
Bonella, Francesco
Renzoni, Elisabetta
Russell, Anne-Marie
Maher, Toby M.
Vancheri, Ada
Bachs, Anna
Avilés, Victoria
Palma, Josep
Bermudo, Guadalupe
Suarez-Cuartin, Guillermo
Tebé, Cristian
Rigo-Bonnin, Raul
Montes-Worboys, Ana
Wijsenbeek, Marlies
Vancheri, Carlo
Gastrointestinal pirfenidone adverse events in idiopathic pulmonary fibrosis depending on diet: the MADIET clinical trial
title Gastrointestinal pirfenidone adverse events in idiopathic pulmonary fibrosis depending on diet: the MADIET clinical trial
title_full Gastrointestinal pirfenidone adverse events in idiopathic pulmonary fibrosis depending on diet: the MADIET clinical trial
title_fullStr Gastrointestinal pirfenidone adverse events in idiopathic pulmonary fibrosis depending on diet: the MADIET clinical trial
title_full_unstemmed Gastrointestinal pirfenidone adverse events in idiopathic pulmonary fibrosis depending on diet: the MADIET clinical trial
title_short Gastrointestinal pirfenidone adverse events in idiopathic pulmonary fibrosis depending on diet: the MADIET clinical trial
title_sort gastrointestinal pirfenidone adverse events in idiopathic pulmonary fibrosis depending on diet: the madiet clinical trial
topic Research Letters
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10586233/
https://www.ncbi.nlm.nih.gov/pubmed/37857429
http://dx.doi.org/10.1183/13993003.00262-2023
work_keys_str_mv AT molinamolinamaria gastrointestinalpirfenidoneadverseeventsinidiopathicpulmonaryfibrosisdependingondietthemadietclinicaltrial
AT shulljessicagermaine gastrointestinalpirfenidoneadverseeventsinidiopathicpulmonaryfibrosisdependingondietthemadietclinicaltrial
AT vicenszygmuntvanesa gastrointestinalpirfenidoneadverseeventsinidiopathicpulmonaryfibrosisdependingondietthemadietclinicaltrial
AT riveraortegapilar gastrointestinalpirfenidoneadverseeventsinidiopathicpulmonaryfibrosisdependingondietthemadietclinicaltrial
AT antonioukaterina gastrointestinalpirfenidoneadverseeventsinidiopathicpulmonaryfibrosisdependingondietthemadietclinicaltrial
AT bonellafrancesco gastrointestinalpirfenidoneadverseeventsinidiopathicpulmonaryfibrosisdependingondietthemadietclinicaltrial
AT renzonielisabetta gastrointestinalpirfenidoneadverseeventsinidiopathicpulmonaryfibrosisdependingondietthemadietclinicaltrial
AT russellannemarie gastrointestinalpirfenidoneadverseeventsinidiopathicpulmonaryfibrosisdependingondietthemadietclinicaltrial
AT mahertobym gastrointestinalpirfenidoneadverseeventsinidiopathicpulmonaryfibrosisdependingondietthemadietclinicaltrial
AT vancheriada gastrointestinalpirfenidoneadverseeventsinidiopathicpulmonaryfibrosisdependingondietthemadietclinicaltrial
AT bachsanna gastrointestinalpirfenidoneadverseeventsinidiopathicpulmonaryfibrosisdependingondietthemadietclinicaltrial
AT avilesvictoria gastrointestinalpirfenidoneadverseeventsinidiopathicpulmonaryfibrosisdependingondietthemadietclinicaltrial
AT palmajosep gastrointestinalpirfenidoneadverseeventsinidiopathicpulmonaryfibrosisdependingondietthemadietclinicaltrial
AT bermudoguadalupe gastrointestinalpirfenidoneadverseeventsinidiopathicpulmonaryfibrosisdependingondietthemadietclinicaltrial
AT suarezcuartinguillermo gastrointestinalpirfenidoneadverseeventsinidiopathicpulmonaryfibrosisdependingondietthemadietclinicaltrial
AT tebecristian gastrointestinalpirfenidoneadverseeventsinidiopathicpulmonaryfibrosisdependingondietthemadietclinicaltrial
AT rigobonninraul gastrointestinalpirfenidoneadverseeventsinidiopathicpulmonaryfibrosisdependingondietthemadietclinicaltrial
AT montesworboysana gastrointestinalpirfenidoneadverseeventsinidiopathicpulmonaryfibrosisdependingondietthemadietclinicaltrial
AT wijsenbeekmarlies gastrointestinalpirfenidoneadverseeventsinidiopathicpulmonaryfibrosisdependingondietthemadietclinicaltrial
AT vanchericarlo gastrointestinalpirfenidoneadverseeventsinidiopathicpulmonaryfibrosisdependingondietthemadietclinicaltrial